Jane Street Group, LLC Aerie Pharmaceuticals Inc Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 17, 2021	SELL	$9.12 - $14.49 $11,855 - $18,837	-1,300 Reduced 10.4%	11,200 $151,000
Q3 2020 Nov 17, 2020	BUY	$10.46 - $14.46 $130,750 - $180,750	12,500 New	12,500 $147,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $578,976 - $1.25 Million	-48,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $500,752 - $761,600	27,200 Added 125.35%	48,900 $940,000
Q2 2018 Aug 15, 2018	BUY	$47.85 - $70.45 $1.04 Million - $1.53 Million	21,700 New	21,700 $1.47 Million
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $230,175 - $274,500	-4,500 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$50.85 - $65.1 $76,275 - $97,649	-1,500 Reduced 25.0%	4,500 $269,000
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $291,600 - $360,600	6,000	6,000 $292,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.